Literature DB >> 22095510

Removal of 3'-phosphate group by bacterial alkaline phosphatase improves oligonucleotide sequence coverage of RNase digestion products analyzed by collision-induced dissociation mass spectrometry.

Kady L Krivos1, Balasubrahmanyam Addepalli, Patrick A Limbach.   

Abstract

RNase mapping by nucleobase-specific endonucleases combined with liquid chromatography/tandem mass spectrometry (LC/MS/MS) is a powerful analytical method for characterizing ribonucleic acids (RNAs). Endonuclease digestion of RNA yields products that contain a 3'-terminal phosphate group. MS/MS via collision-induced dissociation (CID) of these digestion products on a linear ion trap generates fragmentation pathways that include the loss of phosphoric acid (-H(3)PO(4); -98 u), which does not provide information about the sequence of the digestion products and can reduce ion abundance from other pathways that provide sequence information. Here we investigate the use of bacterial alkaline phosphatase (BAP) after RNase digestion to remove the 3'-terminal phosphate from all RNase digestion products prior to LC/MS/MS analysis. RNase digestion products lacking the 3'-phosphate were found to produce CID spectra with more consistent, high-abundance c- and y-type fragment ions as well as significantly more a-Base and w-type ions than digestion products retaining the 3'-phosphate. In this manner, RNase mapping with LC/MS/MS can provide more complete RNA sequence information from fragment ions of higher abundance that are easier to interpret and identify.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22095510     DOI: 10.1002/rcm.5266

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  8 in total

1.  Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity.

Authors:  Mei-Mei Li; Balasubrahmanyam Addepalli; Mei-Juan Tu; Qiu-Xia Chen; Wei-Peng Wang; Patrick A Limbach; Janine M LaSalle; Su Zeng; Min Huang; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2015-05-01       Impact factor: 3.922

2.  Pseudouridine in the Anticodon of Escherichia coli tRNATyr(QΨA) Is Catalyzed by the Dual Specificity Enzyme RluF.

Authors:  Balasubrahmanyam Addepalli; Patrick A Limbach
Journal:  J Biol Chem       Date:  2016-08-22       Impact factor: 5.157

3.  Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization.

Authors:  Wei-Peng Wang; Pui Yan Ho; Qiu-Xia Chen; Balasubrahmanyam Addepalli; Patrick A Limbach; Mei-Mei Li; Wen-Juan Wu; Joseph L Jilek; Jing-Xin Qiu; Hong-Jian Zhang; Tianhong Li; Theodore Wun; Ralph DeVere White; Kit S Lam; Ai-Ming Yu
Journal:  J Pharmacol Exp Ther       Date:  2015-05-28       Impact factor: 4.030

4.  Sequence mapping of transfer RNA chemical modifications by liquid chromatography tandem mass spectrometry.

Authors:  Robert Ross; Xiaoyu Cao; Ningxi Yu; Patrick A Limbach
Journal:  Methods       Date:  2016-03-24       Impact factor: 3.608

5.  Structural and mechanistic basis for enhanced translational efficiency by 2-thiouridine at the tRNA anticodon wobble position.

Authors:  Annia Rodriguez-Hernandez; Jessica L Spears; Kirk W Gaston; Patrick A Limbach; Howard Gamper; Ya-Ming Hou; Rob Kaiser; Paul F Agris; John J Perona
Journal:  J Mol Biol       Date:  2013-05-28       Impact factor: 5.469

6.  Improved RNA modification mapping of cellular non-coding RNAs using C- and U-specific RNases.

Authors:  Priti Thakur; Mariana Estevez; Peter A Lobue; Patrick A Limbach; Balasubrahmanyam Addepalli
Journal:  Analyst       Date:  2020-02-03       Impact factor: 4.616

7.  Analysis of RNA cleavage by MALDI-TOF mass spectrometry.

Authors:  Jeff C Joyner; Kevin D Keuper; J A Cowan
Journal:  Nucleic Acids Res       Date:  2012-08-31       Impact factor: 16.971

8.  Detection of RNA nucleoside modifications with the uridine-specific ribonuclease MC1 from Momordica charantia.

Authors:  Balasubrahmanym Addepalli; Nicholas P Lesner; Patrick A Limbach
Journal:  RNA       Date:  2015-07-28       Impact factor: 4.942

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.